Two pharma giants commit $100M each in part to promote diversity in clinical trials

Bristol Myers Squibb and Johnson & Johnson announced last week that they are going to dedicate $100 million each to promote health equity and diversity efforts. Bristol Myers Squibb, headquartered... To view the full story, click the title link.